Publications by authors named "D Ogaz"
Article Synopsis
- Novel STI prevention methods like doxycycline post-exposure prophylaxis (doxyPEP) and meningococcal B vaccination (4CMenB) are being explored to help control STIs, especially among men and gender-diverse individuals in the UK.
- A survey involving 1,106 participants found that only 34% were aware of antibiotic PEP, with just 8% having reported ever using it; however, 51% expressed an intention to use doxyPEP and 64% for 4CMenB.
- Higher rates of PEP usage and intention to use doxyPEP and 4CMenB were associated with higher sexual risk behaviors and participants who were already using other preventative measures like
Article Synopsis
- GBMSM (gay, bisexual, and men who have sex with men) are at higher risk for sexually transmitted infections and are targeted for vaccinations against diseases like hepatitis and mpox; this study investigates factors affecting their vaccination rates.
- An online survey found that about two-thirds of eligible GBMSM received at least one dose of the vaccinations, with younger bisexual men and those with lower education or unemployment showing lower uptake.
- The findings suggest that, while overall vaccination rates are high, specific populations within GBMSM need more targeted awareness and health promotion efforts to improve vaccination coverage.
During the 2022 multicountry mpox outbreak, the United Kingdom identified cases beginning in May. UK cases increased in June, peaked in July, then rapidly declined after September 2022. Public health responses included community-supported messaging and targeted mpox vaccination among eligible gay, bisexual, and other men who have sex with men (GBMSM).
View Article and Find Full Text PDFArticle Synopsis
- - The Impact Trial evaluated the need and effectiveness of HIV pre-exposure prophylaxis (PrEP) among attendees of sexual health services (SHS) in England from 2017 to 2020, focusing on who could benefit from PrEP and how well it was utilized.
- - The study included over 21,350 participants, predominantly men who have sex with men (95.5%), with a significant uptake of PrEP at 57.1% among those identified as at risk.
- - Findings indicated that many participants engaged with the trial by attending follow-up visits, resulting in a median duration of PrEP use of about 361 days, highlighting its role in HIV prevention strategies.